These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24096044)

  • 1. Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer's disease.
    Xing Y; Jia JP; Ji XJ; Tian T
    Prog Neurobiol; 2013 Dec; 111():53-74. PubMed ID: 24096044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
    Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of estrogen's association with Alzheimer's disease risk by genetic polymorphisms.
    Thornton V; Warden D; Talbot C; Mastana SS; Bandelow S; Hogervorst E
    Brain Res; 2011 Mar; 1379():213-23. PubMed ID: 21211518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
    Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
    Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations.
    Corbo RM; Gambina G; Ruggeri M; Scacchi R
    Dement Geriatr Cogn Disord; 2006; 22(1):67-72. PubMed ID: 16699281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase enzyme and Alzheimer's disease.
    Hiltunen M; Iivonen S; Soininen H
    Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane cholesterol as a mediator of the neuroprotective effects of estrogens.
    Peri A; Benvenuti S; Luciani P; Deledda C; Cellai I
    Neuroscience; 2011 Sep; 191():107-17. PubMed ID: 21396986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of two steroid biosynthesis genes (COMT and CYP17) with Alzheimer's disease in the Italian population.
    Corbo RM; Gambina G; Broggio E; Scarabino D; Scacchi R
    J Neurol Sci; 2014 Sep; 344(1-2):149-53. PubMed ID: 25012481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.
    Goumidi L; Dahlman-Wright K; Tapia-Paez I; Matsson H; Pasquier F; Amouyel P; Kere J; Lambert JC; Meirhaeghe A
    J Alzheimers Dis; 2011; 26(3):431-9. PubMed ID: 21673408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.
    Piccardi M; Congiu D; Squassina A; Manconi F; Putzu PF; Mereu RM; Chillotti C; Del Zompo M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):895-9. PubMed ID: 17503475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant.
    Piacentini S; Polimanti R; Squitti R; Mariani S; Migliore S; Vernieri F; Rossini PM; Manfellotto D; Fuciarelli M
    Neurosci Lett; 2012 Jan; 506(2):203-7. PubMed ID: 22100662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
    Leduc V; Poirier J
    Neurodegener Dis; 2008; 5(3-4):225-7. PubMed ID: 18322397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
    Carter CJ
    Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
    Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
    Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
    Ozturk A; DeKosky ST; Kamboh MI
    Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.